Literature DB >> 24919723

Oxidized high-density lipoprotein impairs the function of human renal proximal tubule epithelial cells through CD36.

Xiang Gao1, Jianxiang Wu2, Yixin Qian1, Lili Fu1, Guiqun Wu1, Chenggang Xu1, Changlin Mei1.   

Abstract

Unlike native high-density lipoprotein (HDL), oxidized HDL exerts adverse effects in a number of diseases, including chronic kidney disease (CKD); however, the mechanisms involved in this process remain unclear. In the present study, we investigated the effects of oxidized HDL on renal tubular cells, which play an important role in the progression of CKD. Human renal proximal tubule epithelial cells (HK-2) were cultured and stimulated with various concentrations of oxidized HDL in the absence or presence of CD36 siRNA. The results revealed that oxidized HDL enhanced the production of reactive oxygen species (ROS) and upregulated the expression of pro-inflammatory factors in the HK-2 cells in a dose-dependent manner. Incubation with oxidized HDL also increased the apoptosis of the HK-2 cells and reduced their migration ability in a dose‑dependent manner. Src family kinase, mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) were activated following stimulation with oxidized HDL. All these effects mediated by oxidized HDL on HK-2 cells were markedly attenuated by transfection with with CD36 siRNA pior to stimulation with oxidized HDL. These findings suggest that oxidized HDL enhances the pro-inflammatory properties and impairs the function of HK-2 cells, mainly through the scavenger receptor, CD36, as well as through the Src, MAPK and NF-κB pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24919723     DOI: 10.3892/ijmm.2014.1799

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

Review 1.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

Review 2.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

3.  Effect of Thymoquinone on Renal Damage Induced by Hyperlipidemia in LDL Receptor-Deficient (LDL-R-/-) Mice.

Authors:  Wanjing Li; Hujin Zhang; Lei Zhang; Taipeng Zhang; Hui Ding
Journal:  Biomed Res Int       Date:  2022-07-06       Impact factor: 3.246

Review 4.  The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury.

Authors:  Zhenzhen Li; Shan Lu; Xiaobing Li
Journal:  Cell Mol Life Sci       Date:  2021-06-29       Impact factor: 9.261

Review 5.  Kidney as modulator and target of "good/bad" HDL.

Authors:  Jianyong Zhong; Haichun Yang; Valentina Kon
Journal:  Pediatr Nephrol       Date:  2018-10-05       Impact factor: 3.714

6.  CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.

Authors:  Yanjuan Hou; Qian Wang; Baosheng Han; Yiliang Chen; Xi Qiao; Lihua Wang
Journal:  Cell Death Dis       Date:  2021-05-21       Impact factor: 8.469

7.  Si-Miao-Yong-An (SMYA) Decoction May Protect the Renal Function Through Regulating the Autophagy-Mediated Degradation of Ubiquitinated Protein in an Atherosclerosis Model.

Authors:  Ze-Bing Zhu; Ke Song; Wei-Jun Huang; Hui Li; Hui Yang; Yun-Qi Bai; Ke-Ting Guo; Rui-Bing Yang; Wen-Jiao Lou; Chen-Hui Xia; Bo Nie; Wei-Jing Liu
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

Review 8.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

9.  Influence of cellular lipid content on influenza A virus replication.

Authors:  Nattavatchara Limsuwat; Chompunuch Boonarkart; Supinya Phakaratsakul; Ornpreya Suptawiwat; Prasert Auewarakul
Journal:  Arch Virol       Date:  2020-03-29       Impact factor: 2.574

Review 10.  High-Density Lipoproteins in Kidney Disease.

Authors:  Valentina Kon; Hai-Chun Yang; Loren E Smith; Kasey C Vickers; MacRae F Linton
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.